The dose is built up slowly over 16 weeks: 0.25 mg in weeks 1 to 4, then 0.5 mg, 1.0 mg, 1.7 mg, and from week 17 the maintenance dose of 2.4 mg once a week
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
This suggests that your body might absorb more levothyroxine than it typically would if taken alone
She also provides ongoing dosing adjustments and monitoring
Liraglutide stands out because of its dosing frequency
This intense central nervous system stimulation frequently leads to severe sleep disturbances, anxiety, and "wired but tired" sensations